Literature DB >> 24787067

YKL-40 in pediatric asthma, MUC5B promoter polymorphism in idiopathic pulmonary fibrosis, and esmolol in septic shock.

Hrishikesh S Kulkarni1, Robert D Guzy, Colleen McEvoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24787067      PMCID： PMC5446197          DOI： 10.1164/rccm.201312-2253RR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

Review 1.  Lung imaging in asthmatic patients: the picture is clearer.

Authors:  Mario Castro; Sean B Fain; Eric A Hoffman; David S Gierada; Serpil C Erzurum; Sally Wenzel
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

2.  The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.

Authors:  Jon R Konradsen; Anna James; Björn Nordlund; Lovisa E Reinius; Cilla Söderhäll; Erik Melén; Asa M Wheelock; Asa Wheelock; Karin C Lödrup Carlsen; Marika Lidegran; Marri Verhoek; Rolf G Boot; Barbro Dahlén; Sven Erik Dahlén; Gunilla Hedlin
Journal:  J Allergy Clin Immunol       Date:  2013-04-26       Impact factor: 10.793

3.  A common MUC5B promoter polymorphism and pulmonary fibrosis.

Authors:  Max A Seibold; Anastasia L Wise; Marcy C Speer; Mark P Steele; Kevin K Brown; James E Loyd; Tasha E Fingerlin; Weiming Zhang; Gunnar Gudmundsson; Steve D Groshong; Christopher M Evans; Stavros Garantziotis; Kenneth B Adler; Burton F Dickey; Roland M du Bois; Ivana V Yang; Aretha Herron; Dolly Kervitsky; Janet L Talbert; Cheryl Markin; Joungjoa Park; Anne L Crews; Susan H Slifer; Scott Auerbach; Michelle G Roy; Jia Lin; Corinne E Hennessy; Marvin I Schwarz; David A Schwartz
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

4.  Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.

Authors:  Christian A Schmittinger; Christian Torgersen; Günter Luckner; Daniel C H Schröder; Ingo Lorenz; Martin W Dünser
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

5.  Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis.

Authors:  M M Parker; J H Shelhamer; C Natanson; D W Alling; J E Parrillo
Journal:  Crit Care Med       Date:  1987-10       Impact factor: 7.598

6.  Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.

Authors:  Talmadge E King; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Phil Hormel; Lisa Lancaster; Paul W Noble; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Roland M du Bois
Journal:  Lancet       Date:  2009-06-29       Impact factor: 79.321

7.  Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.

Authors:  Carole Ober; Zheng Tan; Ying Sun; Jennifer D Possick; Lin Pan; Raluca Nicolae; Sadie Radford; Rodney R Parry; Andrea Heinzmann; Klaus A Deichmann; Lucille A Lester; James E Gern; Robert F Lemanske; Dan L Nicolae; Jack A Elias; Geoffrey L Chupp
Journal:  N Engl J Med       Date:  2008-04-09       Impact factor: 91.245

8.  Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.

Authors:  Andrea Morelli; Christian Ertmer; Martin Westphal; Sebastian Rehberg; Tim Kampmeier; Sandra Ligges; Alessandra Orecchioni; Annalia D'Egidio; Fiorella D'Ippoliti; Cristina Raffone; Mario Venditti; Fabio Guarracino; Massimo Girardis; Luigi Tritapepe; Paolo Pietropaoli; Alexander Mebazaa; Mervyn Singer
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

9.  Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.

Authors:  Anna L Peljto; Yingze Zhang; Tasha E Fingerlin; Shwu-Fan Ma; Joe G N Garcia; Thomas J Richards; Lori J Silveira; Kathleen O Lindell; Mark P Steele; James E Loyd; Kevin F Gibson; Max A Seibold; Kevin K Brown; Janet L Talbert; Cheryl Markin; Karl Kossen; Scott D Seiwert; Elissa Murphy; Imre Noth; Marvin I Schwarz; Naftali Kaminski; David A Schwartz
Journal:  JAMA       Date:  2013-06-05       Impact factor: 56.272

10.  Arterial norepinephrine changes in patients with septic shock.

Authors:  C R Benedict; J A Rose
Journal:  Circ Shock       Date:  1992-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.